Track market-moving stories before they get noisy

NEWTOWN, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at iRhythm Holdings, Inc. (NASDAQ: IRTC). Anyone who has received a data breach notice from iRhythm, or who believes their personal information may have been exposed, can request a free case evaluation.

iRhythm Holdings data breach — at a glance

Company: iRhythm Holdings, Inc. is a San Francisco-based heart-monitoring company and maker of the Zio cardiac monitoring platform, used by approximately 8 million patients in the U.S. and Europe.
Reported: iRhythm disclosed the incident to the U.S. Securities and Exchange Commission on a Form 8-K dated June 10, 2026, and, following its investigation, began notifying impacted individuals on October 2, 2026.
How it happened: An unauthorized party gained access to certain third-party-hosted business applications through social engineering; a threat actor then demanded payment not to disclose the data.
When: The unauthorized access was detected on or around June 8, 2026.
Who may be affected: Patients and others whose personal and protected health information iRhythm maintained and who received a notification.
Status: The total number of individuals affected has not been publicly confirmed; iRhythm has described the incident as material given the volume of data involved.

Cost to you: Nothing. Click here for a free evaluation. What Happened

On or around June 8, 2026, iRhythm detected unauthorized access to certain third-party-hosted business applications and activated its incident response plan. On June 9, 2026, a threat actor claimed to have obtained sensitive information — including patient protected health information — and demanded payment not to disclose it. iRhythm disclosed the incident to the SEC on June 10, 2026, as material given the volume of data involved, and, after completing its investigation, began notifying impacted individuals on October 2, 2026. The total number affected has not been publicly confirmed.

What Personal Information May Be at Risk

According to iRhythm, the information involved varied by individual and may include patient name; contact information (address, email, and phone number); iRhythm patient account number; device serial number; patient insurance number; date of service; and date of birth. iRhythm states it does not store individual financial account or payment card information and has no evidence that any information has been or will be used to commit identity theft.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action on behalf of patients whose sensitive personal and health information may have been compromised. A successful case could recover compensation for losses such as lost time, out-of-pocket costs, and loss of privacy, and could push iRhythm to strengthen how it protects personal information. Anyone who received a breach notification may face an increased risk of identity theft and fraud and is encouraged to come forward. The firm will evaluate your rights and potential claims at no cost.

Recommended Steps to Protect Yourself

Preserve any breach notice you received, and monitor your account statements and credit reports for suspicious activity.Because health and insurance information may be involved, guard against medical identity theft by reviewing explanation-of-benefits statements for services you did not receive.Consider placing a fraud alert or security freeze with Equifax, Experian, and TransUnion, and request your free annual credit reports at annualcreditreport.com. Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492; Email: [email protected]; Web: www.edelson-law.com.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee a similar outcome. The data breach described above is based on iRhythm's public disclosures, including its Form 8-K and subsequent incident update; certain details, including the total number of individuals affected, remain unconfirmed.

GE Vernova (GEV +3.96%) was flagged by a well-known researcher as a top stock buy in the power engineering space after market close on Monday, and investors reacted positively the following day. The company's shares cruised nearly 4% higher on this wave, easily topping the S&P 500 index's 0.3% gain that trading session.

The fabulous four That report came from Oppenheimer, whose analyst, Colin Rusch, singled out four sector stocks he believes are poised to gain substantially.

Image source: Getty Images.

According to Investing.com, the analyst wrote that power technology companies are currently enjoying a period of growth due to numerous factors, not least the eager build-out of facilities supporting the build-out of artificial intelligence (AI).

However, this is occurring at a time of notable macroeconomic insecurity. Conflicts in Europe and, especially, the Middle East have driven up prices for certain commodities and stoked inflation. Businesses and consumers alike are becoming more hesitant to spend, and the products/services power engineering companies offer tend to be expensive.

Premium Feature

Moneyball Superscore

82/100

Today's Change

(

3.96

%) $

39.21

Current Price

$

1,029.21

American heavyweight GE Vernova tops Rusch's "best four in the sector" list. He tagged it as Oppenheimer's No. 1 pick in the space, citing President Trump's August executive order barring imports of bulk power equipment from China. In his view, GE Vernova has significant pricing power in the absence of competition from that part of the world.

In mine, the company doesn't just benefit from the ban on Chinese imports -- it's a market leader on its own as a go-to producer of power-generation equipment crucial for AI build-outs. And with a growing backlog, it looks like it's smack dab in the middle of a high-demand business that could sustain it for years.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends GE Vernova. The Motley Fool has a disclosure policy.

Skydance CEO David Ellison said the newly merged company will be in “the business of rebuilding trust” after the bruising battle to bring together Paramount and Warner Bros. Discovery.

The year-long saga was one of a handful of topics addressed by Ellison and Co-CEO Ynon Kreiz during a press event held Tuesday at the Paramount lot in L.A. The merger officially closed a few hours prior to the gathering.

“This was a turbulent process and, at times, an ugly process,” Ellison said of the period when Paramount outmaneuvered Netflix and Comcast and settled two antitrust lawsuits before closing the $110 billion deal.

With the deal now official, Skydance must “turn the page and make sure that we are in the business of rebuilding trust.”

Executing the goals of the merger, as well as fulfilling the terms of a consent decree reached between Skydance and the plaintiffs who sued to block the deal will help restore belief in the company, Ellison added. With regard to releasing at least 30 films in theaters per year, for example (one of the terms of the consent decree), “the only way you can do that is the creative community coming together,” he added. “When we follow through on all those promises, that’s how we will rebuild trust.”

Asked about whether he felt stung by the attacks on him personally by opponents of the deal, including the thousands of members of the creative community who signed a petition against it, Ellison recalled his history in the business. The onetime actor began producing in his 20s and started work on his production company, Skydance, about 16 years ago, he said.

“I was a big part of that community,” he said of the creative realm, contrasting that with the 14 months he has been a CEO of a large media company. “For more than 15 years, I was an on-set producer” on Skydance projects like Top Gun: Maverick and recent installments in the Mission: Impossible franchise, Ellison reminded the audience. “So, I love this community. I have really good relationships with this community, and I understand that even people who are friends oppose this merger.”

In addition to the merger process, Ellison and Kreiz spoke about the company’s formidable pile of debt, nearly $80 billion worth, as well as plans for streaming, cable TV and film. In all, the on-the-record remarks lasted about 30 minutes and were followed by a larger off-the-record mixer with the media involving additional Skydance executives. The execs sent a hefty memo to employees laying out goals and followed up by convening a town hall.

Notably, the significant layoffs expected at Skydance in order to pay down its debt did not surface as a topic during the media Q&A.

In expanding on his personal experience on the opposite end of his former brothers and sisters in the creative ranks, Ellison zoomed out to the circumstances in the entertainment industry, arguing that the situation required bold action. As Netflix, YouTube, Apple and Amazon steadily began to cut into traditional Hollywood’s revenue streams, the industry was too complacent, he argued. That set the stage for Skydance to take over the much larger Paramount and then make a play for Warner Bros.

“How we got here to a place where Paramount could be acquired, and Warner Brothers could be acquired, is the businesses didn’t disrupt themselves over a decade ago,” Ellison said. “They allowed Netflix to disrupt their business. They allowed Amazon Prime Video to come and disrupt their business. They didn’t transform, and they held on to the past for too long. And, you know, it is a certainty that if you don’t disrupt your business, somebody else will do it.”

The Skydance merger, he said, “is the solution to basically, I believe, that problem.” Combining streaming services and franchise properties will make Skydance “able to compete with the Disneys and Netflixes and Amazons and anybody in the world.”

In that context, he continued, “I think I understand” the wariness of the merger. “I think if you’re being intellectually honest, you need to zoom out and to see that the symptoms of this go back a long time. And when you start asking yourself, what was the alternative? And I believe this genuinely, as somebody who I’ve spent my entire life in this business. I went to film school at USC. I spent 16 years building Skydance. I do genuinely believe this is the best outcome for the industry. I think we will deliver for the creative community. I think we’ll deliver for our shareholders. And the best I can say to our detractors is: Give us time, and we’ll prove it.”

Powell Industries Inc (POWL) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 79/100 On October 06, 2026, Powell Industries Inc POWL shares rose 3.5% to a current price of $204.69, continuing an impressive price performance trend with a year-to-date increase of 92.9%. The stock has fluctuated between a 52-week range of $92.59 and $328.00.

GF Value™ verdict: $204.69 vs. $87.10, 135.0% overvaluedGF Score™: 79/100, indicating an above-average ratingMost notable signal: Insiders sold $68.2M over the past 12 months with no buying activityIs POWL Overvalued or Undervalued?Based on the current price of $204.69, Powell Industries Inc POWL is significantly overvalued when compared to its GF Value™, which is estimated at $87.10. This represents a 135.0% margin of overvaluation. The GF Value™ is GuruFocus' intrinsic value estimate, derived from a combination of historical trading multiples, past business growth, and future performance projections. Given the significant gap between the current price and the GF Value™, investors should be cautious as the stock is trading well above its fair value, suggesting potential risks if the market corrects this discrepancy.

The GF Valuation label categorizes POWL as significantly overvalued, indicating that the current market price is not supported by the underlying fundamentals of the company. This overvaluation could lead to a decline in stock price if market sentiment shifts or if the company's performance does not meet investor expectations in the future.

How Does POWL's Valuation Compare to Its History?MetricCurrentHistoricalP/E (TTM)39.2x22.7xForward P/E29.6x-Powell Industries Inc POWL has a trailing twelve-month (TTM) P/E ratio of 39.2x, which is significantly higher than its 5-year median P/E of 22.7x, indicating that the stock is trading at a premium compared to its historical valuation. This analysis aligns with the GF Value™ verdict, reinforcing the conclusion that POWL is overvalued given its current earnings multiples.

What Does POWL's GF Score™ Tell Us?The GF Score™ is a composite score that assesses a company's financial strength, profitability, growth potential, valuation, and momentum. Powell Industries Inc POWL has a GF Score™ of 79 out of 100, indicating a solid overall performance but highlighting significant areas for concern, particularly regarding valuation.

MetricRatingGF Score™79Financial Strength8/10Profitability6/10Growth10/10Valuation1/10Momentum10/10The strong growth rank of 10/10 indicates robust potential for future expansion, while the financial strength of 8/10 suggests a solid balance sheet. However, the valuation rank of 1/10 highlights a significant concern, as it suggests the stock is highly overvalued relative to its fundamentals. The momentum rank of 10/10 shows that the stock has been performing well recently, but this could be misleading given the overvaluation risk.

What Are Gurus and Insiders Doing with POWL?Currently, seven gurus hold positions in Powell Industries Inc POWL, with four adding to their holdings and three trimming their positions in recent quarters. This mixed signal from gurus indicates a lack of consensus on the stock's future performance. However, insider activity shows a concerning trend, with insiders selling $68.2 million worth of shares over the past 12 months and no buying activity reported. This lack of insider confidence can be a red flag for potential investors as it may signal doubts about the company's future performance or valuation.

What This Means for InvestorsBased on the analysis of the GF Value™, Powell Industries Inc POWL appears to be significantly overvalued. With a current price well above its estimated fair value and concerning insider selling patterns, investors should approach this stock with caution. It is crucial to consider both the growth potential and the risks associated with an inflated valuation. For further insights, visit the Powell Industries Inc (POWL) stock page, or explore the GF Value™ page for more details.

Frequently Asked QuestionsWhat is POWL's GF Score™?

POWL has a GF Score™ of 79/100, which indicates an above-average rating in terms of its overall performance and fundamental health.

Is POWL overvalued or undervalued?

POWL is currently overvalued, with a GF Value™ of $87.10 compared to its current price of $204.69.

What is POWL's P/E ratio?

The P/E ratio for POWL is 39.2x TTM, which is significantly higher than its 5-year median P/E of 22.7x, indicating that the stock is trading at a premium compared to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

In Brief

Posted:

Image Credits:Apple Apple is working on a new ecosystem of smart home devices via a partnership with LG, Bloomberg has reported.

The new devices — which include a smart lock, a thermostat, and a doorbell — are designed to integrate with the company’s smart home hub, another upcoming product that will reportedly launch on October 13. That hub is expected to include a 6-inch square display that can be placed on a countertop or mounted on a wall.

The two companies are also working on a slate of security cameras, including models for indoor and outdoor, was well as a floodlight. The LG devices are expected to be announced, if not formally released, next week, too. TechCrunch reached out to Apple for more information.

Interestingly, the devices will reportedly carry the LG brand — despite being developed by both companies.

The new products could aptly be read as a swipe at Amazon’s smart home offerings, which currently include a variety of similar products, including its Ring home security cameras.

Apple has sought to push into new territory with its recent hardware releases. One of those new territories is an expanded smart home presence.

Topics

Subscribe for the industry’s biggest tech news

Latest in Hardware

Procter & Gamble (PG - Free Report) closed the most recent trading day at $148.41, moving +1.69% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.49%, and the technology-dominated Nasdaq saw an increase of 0.45%.

Shares of the world's largest consumer products maker have depreciated by 0.34% over the course of the past month, outperforming the Consumer Staples sector's loss of 4.89%, and lagging the S&P 500's gain of 0.84%.

The investment community will be paying close attention to the earnings performance of Procter & Gamble in its upcoming release. The company is slated to reveal its earnings on October 22, 2026. The company is predicted to post an EPS of $1.89, indicating a 5.03% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $22.68 billion, indicating a 1.33% upward movement from the same quarter last year.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.98 per share and revenue of $88.67 billion. These totals would mark changes of +1.31% and +1.88%, respectively, from last year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Procter & Gamble. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.04% downward. Procter & Gamble is currently sporting a Zacks Rank of #3 (Hold).

In terms of valuation, Procter & Gamble is presently being traded at a Forward P/E ratio of 20.9. This valuation marks a premium compared to its industry average Forward P/E of 19.41.

We can additionally observe that PG currently boasts a PEG ratio of 3.62. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Consumer Products - Staples industry had an average PEG ratio of 2.46 as trading concluded yesterday.

The Consumer Products - Staples industry is part of the Consumer Staples sector. Currently, this industry holds a Zacks Industry Rank of 195, positioning it in the bottom 21% of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

 | Source: Digital Realty

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, announced today that Digital Euro Finco, LLC, a wholly owned indirect finance subsidiary of the company’s operating partnership, Digital Realty Trust, L.P., priced an offering of €1 billion aggregate principal amount of 5.125% Guaranteed Notes due 2036 at a price of 99.289% of the principal amount (the “Euro Notes”).

The Euro Notes will be senior unsecured obligations of Digital Euro Finco, LLC and will be fully and unconditionally guaranteed by the company and the operating partnership. Interest on the Euro Notes will be payable annually in arrears at a rate of 5.125% per annum from and including October 9, 2026 and will mature on October 9, 2036. Closing of the offering is expected to occur on October 9, 2026, subject to the satisfaction of customary closing conditions.

The company intends to allocate an amount equal to the net proceeds from the offering of the Euro Notes to finance or refinance, in part or in full, new and/or existing projects consistent with Digital Realty’s Green Bond Framework, including the development and redevelopment of such projects. Pending the allocation of the net proceeds of the Euro Notes to such projects, all or a portion of an amount equal to the net proceeds from the Euro Notes may be used to temporarily repay borrowings outstanding under the operating partnership’s global revolving credit facilities, acquire additional properties or businesses, fund development opportunities, invest in interest-bearing accounts and short-term, interest-bearing securities which are consistent with the company’s intention to qualify as a REIT for U.S. federal income tax purposes, and to provide for working capital and other general corporate purposes, including potentially for the repayment of other debt, or the redemption, repurchase, repayment or retirement of outstanding equity or debt securities, or a combination of the foregoing.

The Euro Notes are being sold only outside the United States in reliance on Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Euro Notes have not been and will not be registered under the Securities Act and may not be offered or sold in the United States or to United States persons (within the meaning of Regulation S under the Securities Act) absent registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Euro Notes, nor shall there be any offer, solicitation or sale of the Euro Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Safe Harbor Statement

This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the timing and consummation of the offering of the Euro Notes and the expected use of the net proceeds. The company can provide no assurances that it will be able to complete the offering on the anticipated terms, or at all. For a further list and description of such risks and uncertainties, see the company’s reports and other filings with the U.S. Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2025 and the Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Reg S Statement

This communication is not an offer to sell or a solicitation of an offer to buy securities of Digital Realty Trust, Inc. or its subsidiaries. The securities have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States. Consequently, the securities may not be offered, sold, resold, transferred, delivered or distributed, directly or indirectly, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Any offering of the securities will be conducted pursuant to Regulation S under the Securities Act.

Notice to European Economic Area Retail Investors

The Euro Notes are not intended to be offered, sold or otherwise made available to and, with effect from such date, should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); or (ii) a customer within the meaning of Directive 2016/97/EU (as amended, the “IMD”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. No key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling any in scope instrument or otherwise making such instruments available to retail investors in the EEA has been prepared. Offering or selling the Euro Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. This communication has been prepared on the basis that any offers or sales of Euro Notes in any Member State of the EEA will be made pursuant to an exemption under Regulation (EU) 2017/1129 (as amended or superseded, the “Prospectus Regulation”) from the requirement to publish a prospectus for offers or sales of Euro Notes. This communication is not a prospectus for the purposes of the Prospectus Regulation.

Notice to UK Retail Investors

This announcement is for distribution only to, and is directed at, persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”), (ii) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

The Euro Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000, as amended (the “FSMA”) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA (“UK MiFIR”). Consequently, no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Euro Notes or otherwise making them available to retail investors in the United Kingdom has been prepared and therefore offering or selling the Euro Notes or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.

Relevant stabilization regulations including FCA/ICMA apply. Manufacturer target market (MIFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or UK.

Investor Relations
Jordan Sadler / Jim Huseby
Digital Realty
+1 (737) 281-0101
[email protected]

Don't look now, but one of the hottest tickets in tech industry events is being led by cybersecurity specialist CrowdStrike (CRWD +2.27%). On news that an upcoming industry conference it's helming has already set records, investors eagerly bought the stock, sending it to a more than 2% gain on Tuesday. CrowdStrike also received a substantial price target increase from an analyst.

The wisdom of crowds That morning, CrowdStrike announced that its upcoming Fal.Con Europe2026 event has sold out, reaching capacity more quickly than ever in its three-year history. On top of that, registrations were up a meaty 60% over last year's conference.

Image source: Getty Images.

Over the decade CrowdStrike has been running Fal.Con (at least in its native U.S.) it has grown into a major event for the cybersecurity industry. This bolsters the case for CrowdStrike as a bellwether company in its sector, and a pacesetting business that others want to listen to and learn from.

Separately, the company's equity was the focus of a new analyst note, and a positive one at that. StoneX analyst Yi Fu Lee upped his price target on CrowdStrike shares to $325 apiece, well up from his previous $250. Almost needless to say, he maintained his buy recommendation.

Premium Feature

Moneyball Superscore

85/100

Today's Change

(

2.27

%) $

6.19

Current Price

$

278.86

Growing AI fears The excited and enthusiastic reaction to the next Fal.Con Europe indicates that cybersecurity is, if anything, an even hotter focus of attention than it was in years past. I'd say much of this stems from recent issues in artificial intelligence (AI) development, such as incidents where certain models strayed from their assigned tasks during deployment.

Like numerous peer companies, CrowdStrike has been concentrating on AI security lately. That, plus its position as the operator of the Fal.Con conferences, is sure to keep it on the list of elite cybersecurity businesses for both clients and investors.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CrowdStrike. The Motley Fool has a disclosure policy.

Leidos (LDOS - Free Report) ended the recent trading session at $116.69, demonstrating a -2.31% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.49%, and the technology-dominated Nasdaq saw an increase of 0.45%.

Heading into today, shares of the security and engineering company had lost 10.22% over the past month, lagging the Computer and Technology sector's gain of 6.31% and the S&P 500's gain of 0.84%.

Market participants will be closely following the financial results of Leidos in its upcoming release. It is anticipated that the company will report an EPS of $3, marking a 1.64% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $4.72 billion, up 5.52% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $12.28 per share and revenue of $18.29 billion, which would represent changes of +2.42% and +6.52%, respectively, from the prior year.

Any recent changes to analyst estimates for Leidos should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 0.86% fall in the Zacks Consensus EPS estimate. Leidos presently features a Zacks Rank of #4 (Sell).

In terms of valuation, Leidos is presently being traded at a Forward P/E ratio of 9.73. This valuation marks a discount compared to its industry average Forward P/E of 13.31.

One should further note that LDOS currently holds a PEG ratio of 1.34. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Computers - IT Services industry had an average PEG ratio of 1.34 as trading concluded yesterday.

The Computers - IT Services industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 94, putting it in the top 39% of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Ultragenyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On September 2, 2026, Ultragenyx issued a press release “announc[ing] results from the Phase 3 Aspire study for apazunersen (GTX-102) in Angelman syndrome.”  Per the press release, “[t]he study did not achieve the primary endpoint of change from Baseline in Bayley-4 cognitive raw score nor the key secondary endpoint of net response in Multidomain Responder Index (MDRI).” 

On this news, Ultragenyx’s stock price fell $11.68 per share, or 44.03%, to close at $14.85 per share on September 3, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Integra (IART) To Contact Him Directly To Discuss Their Options

If you purchased or acquired stock in Integra and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.

Click here to participate in the action.

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) --

What’s Happening:

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART) on behalf of Integra stockholders. Our investigation concerns whether Integra has violated the federal securities laws and/or engaged in other unlawful business practices.
Investigation Details:

On October 2, 2026, Integra released its third quarter 2026 financial results, revealing a quarterly revenue of $410 million to $412 million, below consensus estimates of $416.3 million. Additionally, the Company lowered its full-year 2026 revenue guidance to $1.634 billion to $1.654 billion from $1.654 billion to $1.695 billion. The Company attributed its revenue results and guidance cut to “the July flooding event at our Cincinnati facility,” which “caused damage to portions of the facility, equipment, inventory and other assets and resulted in operational disruption to the site.” Integra stated that the “flooding related supply disruption negatively impacted third quarter revenue by approximately $7 million and is expected to negatively impact fourth quarter revenue by approximately $15 million to $20 million.” Additionally, the Company does not expect the Cincinnati facility to “return to full manufacturing operations” until second quarter 2027. During the Company’s second quarter 2026 earnings call, however, Integra CFO Lea Daniels Knight had stated the Company did “not expect the event to have a material impact on our revenue or EPS guidance for 2026.” Following the October 2, 2026 disclosure, the price of Integra shares declined by $3.41 per share, or approximately 21.2%, from $16.09 per share on October 1, 2026 to close at $12.68 on October 2, 2026.
Next Steps:

If you purchased or otherwise acquired Integra shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of D-Wave Quantum Inc. (“D-Wave” or the “Company”) (NASDAQ: QBTS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether D-Wave and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 6, 2026, D-Wave reported its financial results for the second quarter of 2026.  Among other items, D-Wave issues revenue of only $3.08 million, compared to $3.1 million for the same period in the prior year, and missing analyst expectations in the range of $4.03 million to $4.08 million. 

On this news, D-Wave’s stock price fell $1.99 per share, or 9.28%, to close at $19.41 per share on August 6, 2026. 

Then, on August 25, 2026, D-Wave issued a press release “announc[ing] that John Markovich is retiring and thus resigning from his position as Chief Financial Officer effective September 2, 2026.” 

On this news, D-Wave’s stock price fell $1.84 per share, or 9.51%, to close at $17.51 per share on August 26, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

CoreWeave stock climbed to $91.90 on Tuesday, tracking gains across other neocloud companies such as IREN and Nebius. The shares are now up more than 50% from their lowest level this year. Still, despite this strong rally, the company faces substantial risks ahead.

The ongoing CRWV stock rebound is happening as companies in the artificial intelligence (AI) industry soar. Nvidia, the biggest company in the world, jumped and is now approaching the $6 trillion market capitalization level. AMD jumped by 3.6%, while Dell and Broadcom are up. 

CoreWeave is a big player in the AI space, where it offers computing solutions to the biggest AI companies in the world, like Anthropic, OpenAI, and Microsoft.

It has become the biggest player in the neocloud industry, with its revenue backlog rising to over $104 billion. Its biggest deals include a $35 billion partnership with Meta, $22 billion one with OpenAI, and a $6 billion one with Jane Street. 

The most recent financial results showed that CoreWeave’s business continued soaring, with its quarterly revenue rising by 112% to $2.6 billion. This revenue is expected to grow in the foreseeable future. Yahoo Finance data shows that analysts estimate that its annual revenue will hit $12.87 billion this year, up by 150% from a year earlier. It is then expected to more than double to $26.7 billion next year.

Despite the optimism, CoreWeave faces some major risks, which explains why the stock is still in a bear market. One of the risks is that its capital expenditure continues rising. It plans to spend between $35 billion and $39 billion this year. It has already spent over $29.2 billion in the last five quarters.

Capital expenditure will likely continue growing as the cost of key equipment like servers, GPUs, CPUs, and storage. This, in turn, will push the company to raise more money through debt and equity over time. 

Additionally, there are concerns about depreciation, which is significant. In the last earnings report, the company said that its depreciation and amortization jumped to over $1.3 billion, up from $560 million in the same period last year. Its D&A figure accounted for over 52% of its total revenue. 

CoreWeave’s challenge is that it will need to keep spending on GPUs as new models come online. Michael Burry believes that these GPUs have a 2- to 3-year useful life stretch, while CoreWeave assumes over 5. This view explains why its bond yields are rising. Those with maturities of 2032 are yielding 11.3%. Just recently, it raised $1.1 billion through a junk bond offering.

CoreWeave stock is also facing the challenge of rising competition. Nscale, a British company, has seen its backlog jump to over $104 billion, while Lambda is raising $4 billion at a $14.5 billion valuation. Most Bitcoin mining companies like Riot Platforms and MARA Holdings, have all diversified into the AI data center industry.

CRWV stock chart | Source: TradingView

The daily chart shows that CoreWeave stock has moved sideways in the past few days. A closer look, however, shows that it has formed a head-and-shoulders pattern whose neckline is at $66.55. H&S is one of the riskiest patterns in technical analysis.

The stock has continued to consolidate along the 50-day and 100-day Exponential Moving Averages (EMA). The most likely scenario is where the stock remains under pressure and retests the support level of $66.55. A break below that level will point to more downside.

SummaryAT&T remains a 'Buy' for risk-conscious, income-focused investors, offering a high dividend yield and solid free cash flow.T's valuation is fair, with shares trading near 10x normalized EPS and limited fundamental upside, but supported by reliable income.Recent results highlight robust growth in Advanced Connectivity, fiber, and wireless, with positive EPS revision trends and a $10 billion buyback objective.Technical setup is mixed; key resistance at $27 and congestion in the low-to-mid $20s may limit near-term upside. jetcityimage/iStock Editorial via Getty Images

Dividend stocks have taken a beating since mid-August. That's when Treasury yields really began their upward march. Shares of tech-sector companies have performed very well amid the bond selloff, but value areas continue to struggle, particularly on a relative basis. But the Q3 earnings season

9.81K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

 | Source: Kinross Gold Corporation

TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) (the “Company”) will release its financial statements and operating results for the third quarter of 2026 on Wednesday, October 28, 2026, after market close. On Thursday, October 29, 2026, at 8:00 a.m. EDT Kinross will hold a conference call and audio webcast to discuss the results, followed by a question-and-answer session. The call-in numbers are as follows:

Canada & US toll-free – (888) 596-4144; Conference ID: 9425112
Outside of Canada & US – +1 (646) 968-2525; Conference ID: 9425112

Replay (available up to 14 days after the call):

Canada & US toll-free – +1 (800) 770-2030; Conference ID: 9425112 #
Outside of Canada & US – +1 (609) 800-9909; Conference ID: 9425112 #

You may also access the conference call on a listen-only basis via webcast at our website www.kinross.com. The audio webcast will be archived on www.kinross.com.

About Kinross Gold Corporation

Kinross is a Canadian-based global senior gold mining company with operations and projects in the United States, Brazil, Mauritania, Chile and Canada. Our focus is on delivering value based on the core principles of responsible mining, operational excellence, disciplined growth, and balance sheet strength. Kinross maintains listings on the Toronto Stock Exchange (symbol: K) and the New York Stock Exchange (symbol: KGC).

Media Contact
Samantha Sheffield
Senior Director, Corporate Communications
phone: 416-365-3034
[email protected]

Investor Relations Contact
David Shaver                                 
Executive Vice-President, Investor Relations & Communications                
phone: 416-365-2854                        
[email protected]

Source: Kinross Gold Corporation

 | Source: Digital Realty

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), a leading global provider of carrier- and cloud-neutral data center, colocation and interconnection solutions, announced today that Digital Constellation B.V., an indirect wholly-owned finance subsidiary of the company’s operating partnership, Digital Realty Trust, L.P., has closed an offering of CHF225 million of 1.6803% Swiss bonds due 2029 (the “2029 Swiss bonds”), CHF185 million of 2.0600% Swiss bonds due 2032 (the “2032 Swiss bonds”) and CHF100 million of 2.4150% Swiss bonds due 2036 (the “2036 Swiss bonds” and together with the 2029 Swiss bonds and the 2032 Swiss bonds, the “Swiss bonds”).  

The Swiss bonds will be senior unsecured obligations of Digital Constellation B.V. and will be fully and unconditionally guaranteed by the company, the operating partnership and Digital Intrepid Holding B.V., an indirect wholly-owned holding and finance subsidiary of the operating partnership. Interest on the 2029 Swiss bonds will be payable annually in arrears at a rate of 1.6803% per annum from and including October 6, 2026, and the 2029 Swiss bonds will mature on October 8, 2029. Interest on the 2032 Swiss bonds will be payable annually in arrears at a rate of 2.0600% per annum from and including October 6, 2026, and the 2032 Swiss bonds will mature on October 6, 2032. Interest on the 2036 Swiss bonds will be payable annually in arrears at a rate of 2.4150% per annum from and including October 6, 2026, and the 2036 Swiss bonds will mature on October 6, 2036.

The company intends to use the net proceeds from the offering of the Swiss bonds to allocate an amount equal to the net proceeds from the offering of the Swiss bonds to finance or refinance, in part or in full, new and/or existing projects consistent with Digital Realty’s Green Bond Framework, including the development and redevelopment of such projects. Pending the allocation of the net proceeds of the Swiss bonds to such projects, all or a portion of an amount equal to the net proceeds from the Swiss bonds may be used to temporarily repay borrowings outstanding under the operating partnership’s global revolving credit facilities, acquire additional properties or businesses, fund development opportunities, invest in interest-bearing accounts and short-term, interest-bearing securities which are consistent with the company’s intention to qualify as a REIT for U.S. federal income tax purposes, and to provide for working capital and other general corporate purposes, including potentially for the repayment of other debt, or the redemption, repurchase, repayment or retirement of outstanding equity or debt securities, or a combination of the foregoing.   

The Swiss bonds are being sold only outside the United States in reliance on Regulation S under the U.S. Securities Act of 1933, as amended. The Swiss bonds have not been and will not be registered under the Securities Act and may not be offered or sold in the United States or to United States persons (within the meaning of Regulation S under the Securities Act) absent registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Swiss bonds, nor shall there be any offer, solicitation or sale of the Swiss bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful.  

Safe Harbor Statement
This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see the company’s reports and other filings with the U.S. Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2025 and the Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  

Regulation S Statement
This communication is not an offer to sell or a solicitation of an offer to buy securities of Digital Realty Trust, Inc. or its subsidiaries. The securities have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States. Consequently, the securities may not be offered, sold, resold, transferred, delivered or distributed, directly or indirectly, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Any offering of the securities will be conducted pursuant to Regulation S under the Securities Act.  

Notice to European Economic Area Retail Investors
The Swiss bonds are not intended to be offered, sold or otherwise made available to and, with effect from such date, should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); or (ii) a customer within the meaning of Directive 2016/97/EU (as amended, the “IMD”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. No key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling any in scope instrument or otherwise making such instruments available to retail investors in the EEA has been prepared. Offering or selling the Swiss bonds or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. This communication has been prepared on the basis that any offers or sales of Swiss bonds in any Member State of the EEA will be made pursuant to an exemption under Regulation (EU) 2017/1129 (as amended or superseded, the “Prospectus Regulation”) from the requirement to publish a prospectus for offers or sales of Swiss bonds. This communication is not a prospectus for the purposes of the Prospectus Regulation.

Notice to UK Retail Investors

This announcement is for distribution only to, and is directed at, persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”), (ii) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

The Swiss bonds are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to any retail investor in the United Kingdom. For these purposes, a “retail investor” means a person who is either one (or both) of the following): (i) not a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018; or (ii) not a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024”. Consequently, no disclosure document required by the Financial Conduct Authority Product Disclosure Sourcebook for offering, selling or distributing the Swiss bonds or otherwise making them available to retail investors in the U.K. has been prepared and therefore offering, selling or distributing the Swiss bonds or otherwise making them available to any retail investor in the U.K. may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulation 2024.

Investor Relations
Jordan Sadler / Jim Huseby
Digital Realty
+1 (737) 281- 0101
[email protected]

 | Source: Scotts Miracle-Gro Company (The)

MARYSVILLE, Ohio, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), home to North America’s leading consumer lawn and garden brands, today announced the naming of Prathima Hegde to senior vice president and chief information officer.

In this new role, Hegde will lead enterprise IT with a focus on driving technology modernization, operational excellence, AI integration and digital capabilities to advance the SMG multi-year growth strategy and the evolution into a consumer lifestyle company. She also will support the implementation of SAP S/4HANA. Hegde reports to President and CEO Nate Baxter as a key member of the leadership team.

"The modernization of our enterprise systems will enhance our ability to exceed consumer expectations, complementing our high-performing products with seamless digital experiences and expert guidance to serve as the trusted partner for bringing their living spaces to life," Baxter said. "Our technology upgrades will also directly power each of our SMG 2.0 building blocks by enabling product innovation, omnichannel and retail expansion, category growth and operational efficiencies.

“Prathima’s experience is directly relevant to where we are headed. She brings exceptional expertise in leading complex digital transformations and aligning technology with business outcomes. She will play a vital role in modernizing our technology core, enhancing productivity through automation and AI, and further strengthening ScottsMiracle-Gro for sustainable growth.”

Hegde has more than two decades of enterprise technology leadership across consumer packaged goods, manufacturing, healthcare and education. Most recently, as CIO of Del Monte Foods, she spearheaded enterprise IT strategy, cloud modernization, data analytics and AI initiatives. Previously, as head of corporate applications at Tropicana Brands Group, she led the technology spinoff from PepsiCo, building modern digital platforms. She has also served in senior IT roles at Adtalem Global Education and Abbott Laboratories. Hegde holds an MBA in strategy and finance from the University of Chicago Booth School of Business and a Bachelor of Science in microbiology from Osmania University.

SMG 2.0 Growth Strategy

The Company previously announced its multi-year SMG 2.0 strategy for sustainable growth and long-term shareholder value. Its building blocks include:

Portfolio optimization and innovation to drive premium growth.Omnichannel and retail expansion to engage broader consumer groups.Category and market expansion to grow the Company’s addressable market.Technology-driven operational excellence with a focus on expanding margins via targeted AI, automation and supply chain efficiencies. About ScottsMiracle-Gro
With approximately $3.3 billion in sales, the Company is the leading marketer of branded consumer lawn and garden products in North America. The Company’s brands are among the most recognized in the industry. The Company’s Scotts®, Miracle-Gro®, Ortho® and Tomcat® brands are market-leading in their categories. For additional information, visit us at www.scottsmiraclegro.com

For investor inquiries:
Brad Chelton
Vice President
Treasury, Tax and Investor Relations
[email protected]
(937) 309-2503

For media inquiries:
Tom Matthews
Chief Communications Officer
[email protected]
(937) 844-3864

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new artificial intelligence (AI) capabilities to help researchers analyze complex biological and genomic data faster while keeping the scientific evidence behind the results visible.

The expansion includes IPA Investigator, a new AI research companion for QIAGEN Ingenuity Pathway Analysis (IPA), and the new QIAGEN Discovery Platform, which extends these capabilities into automated drug discovery workflows.

The new offerings build on more than 25 years of biomedical knowledge from QIAGEN Digital Insights (QDI), whose bioinformatics solutions are used by around 150,000 users. The global market for AI in bioinformatics is projected to more than double from about $12 billion in 2026 to more than $25 billion by 2031, according to Mordor Intelligence.

As researchers increasingly use AI to analyze growing volumes of biological and genomic data, speed alone is not enough. QIAGEN combines AI with expert-reviewed biological, genomic and clinical information so scientists can examine the evidence behind the results.

“AI can deliver an answer in seconds, but in science, speed without evidence can create false confidence,” said Dominic John, Vice President and Head of QIAGEN Digital Insights. “Our approach is to combine the speed of AI with expert-curated biomedical knowledge and traceable scientific evidence so researchers can examine the evidence behind the results and evaluate them for themselves.”

IPA Investigator allows scientists to ask questions about their data in natural language. It can identify relevant biological relationships, recommend analyses and carry them out within IPA. Researchers can then connect their own experimental data with existing biological knowledge to better understand disease, identify potential drug targets and decide what to investigate next.

At the University of Bergen in Norway, researchers tested IPA Investigator using complex datasets that deliberately introduced misleading sample comparisons.

“We deliberately introduced misleading comparisons to see how IPA Investigator would respond. It identified the problem, cautioned us against overinterpreting the results and suggested a better experimental design,” said Dr. Simona Chera, Professor at the University of Bergen.

QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical knowledge base and molecular data to support drug discovery. The platform is designed to help researchers identify potential drug targets and biomarkers, generate research hypotheses and automate parts of the discovery process.

The launches are part of a broader rollout of AI across QIAGEN Digital Insights, including AI-powered translation in QIAGEN Clinical Insight (QCI) Interpret and machine learning combined with expert-reviewed information in Franklin by QIAGEN.

For more information about QIAGEN Digital Insights, visit: https://digitalinsights.qiagen.com/.

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and Molecular Diagnostics (clinical healthcare). As of June 30, 2026, QIAGEN employed about 5,500 people across more than 35 locations. For more information, visit www.qiagen.com.

Forward-Looking Statement

Certain statements in this press release may constitute forward-looking statements within the meaning of the U.S. federal securities laws. These statements include, among others, statements regarding QIAGEN’s products, product development and launches, regulatory approvals, market opportunities and future business performance. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. These risks include, among others, the development and commercial success of new products, regulatory approvals, competition, changes in customer demand and funding, economic and market conditions, supply chain disruptions, cybersecurity incidents, litigation and other risks described under “Risk Factors” in QIAGEN’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission. QIAGEN undertakes no obligation to update any forward-looking statement except as required by law.

Source: QIAGEN N.V.

Category: Bioinformatics

More News From QIAGEN N.V.

powered by

FCEL buy

Buy FuelCell Energy (FCEL). The Fit Energy deal is a clear “time-to-power” wedge: behind-the-meter fuel cells for data centers that can’t wait on grid queues. The stock also reclaimed the 50- and 100-day moving averages, signaling momentum plus a real catalyst. Thesis: more hyperscale/AI power demand shifts from utility interconnects to distributed generation, and FCEL converts partnerships into megawatt deployments.

Key Risk: FCEL fails to convert these announcements into firm, high-margin contracts and deliveries—execution slips keep losses widening and the stock gives back the rally.

FCEL momentum hedge via short-term put spread

Sell short-dated downside protection against the rally by buying a put spread on FuelCell Energy (FCEL) while taking the long. The catalyst is strong, but the article flags execution and profitability risk; a put spread limits damage if the market reverses after the initial headline pop. Thesis: upside continues near-term, but volatility stays high until conversion metrics improve.

Key Risk: A sharp selloff driven by worsening financials or a failed project conversion overwhelms the technical/momentum support, making the put spread insufficient to protect the position.

FuelCell Energy FCEL stock gained on Tuesday due to renewed enthusiasm surrounding the firm’s strategic partnership with Fit Energy.

In a press release this morning, Fit Energy said it plans on powering a new data center development in Pennsylvania, using FCEL’s natural gas fuel cells.

The announcement arrives at a time when FuelCell shares are already regaining momentum – now up more than 40% versus their recent low.

The primary driver behind today’s price action is the market’s growing realization that electrical grid capacity bottlenecks are forcing tech giants right into the arms of distributed fuel cell makers.

With the rapid expansion of hyperscale cloud computing and artificial intelligence (AI) workloads requiring continuous baseline electricity, data center operators face multi-year queues for standard utility grid connections.

FCEL’s agreement with Fit Energy, which targets up to 380 MW of behind-the-meter generation, offers on-site, low-carbon power that bypasses grid interconnections.

This provides data center firms with a crucial “time-to-power” advantage.

Note that the sharp rally in FuelCell stock on October 6th drove it decisively above its 50-day and 100-day moving averages (MAs), indicating bullish momentum could sustain in the near term.

While today’s surge in FCEL stock highlights strong bullish sentiment, prospective investors must carefully assess the risk-reward profile before jumping in.

On one hand, FuelCell boasts a “growing backlog” of multi-megawatt projects and clean power purchase agreements that position it directly at the intersection of AI energy demand and grid decarbonization.

But on the other hand, the company faces ongoing financial and execution scrutiny.

Recent class-action shareholder litigation detailed a $17.0 million charge in Q3 related to Phase 0 contractual pricing and an annualized production rate that dropped to approximately 37.1 MW.

Plus, net losses stood at $45.3 million on $33.0 million in revenue for the quarter ending July 2026, suggesting that buying at current levels requires a high tolerance for operational friction.

Looking ahead, FuelCell Energy’s multi-year trajectory hinges on execution discipline rather than speculative demand.

Investors evaluating the clean energy stock today must look beyond headline momentum and focus on how efficiently the management team scales production capacity to meet its megawatt delivery commitments.

The critical metric to track over the coming quarters is not merely “non-binding project pipelines” or preliminary announcements – but the concrete conversion rate of those agreements into firm, high-margin commercial revenue.

For long-term investors seeking high-upside exposure to the global data center power crisis, FCEL shares present a compelling play, but short-term traders should prepare for sharp volatility as the market balances data center enthusiasm against near-term profitability targets.

Note that Wall Street currently rates FuelCell Energy at Moderate Buy.

Today's Change

(

12.27

%) $

1.52

Current Price

$

13.91

Corteva (CTVA +12.27%), a pure-play crop protection provider, closed at $13.91, up 12.27% after JPMorgan upgraded Corteva in premarket trading. Investors are watching how the company will fare as a stand-alone company, now separate from its seed genetics business. Trading volume reached 38.9M shares, coming in about 285% above its three-month average of 10.1M shares.

How the markets moved todayThe S&P 500 (^GSPC +0.58%) closed at 7,820, up 0.59%, while the Nasdaq Composite (^IXIC +0.45%) finished at 27,600, up 0.45%. Among agricultural inputs peers, Bayer (BAYRY +0.24%) closed at $12.45, up 0.40%, and FMC (FMC +0.33%) closed at $9.02, up 0.22%; the group stayed on investors' radar as Corteva's upgrade and index reshuffling drew attention.

What this means for investorsIt looks like Corteva is quickly becoming a Joel Greenblatt "special" of sorts following its recent separation from Vylor. While Vylor split with the "more interesting" business of seed genetics and a century-old germplasm library, Corteva's discounted, pure-play crop protection operations are worthy of not being forgotten about -- at least according to an analyst at JPMorgan.

Setting a $19 price target on CTVA stock, JPMorgan's bullish outlook on Corteva helped the latter's share jump 12% today. While uncertainty surrounds Corteva due to PFAS and PFOA legal liabilities inherited from its past ties to DuPont, JPM believes these costs should peak at $1.3 billion, or roughly $2 per share for Corteva, according to its modeling.

JPMorgan's $19 price target on CTVA stock reflects this expected impact, implying it still sees 37% upside in the stock. Trading at just 5.7 times the company's estimated 2027 EBITDA, Corteva might be an interesting deep-value opportunity for investors comfortable operating in this industry, but the legal liabilities worry me too much, personally, even with the company's pristine balance sheet.

Crocs, Inc. (NASDAQ:CROX) (NASDAQ: CROX), the casual footwear company, is expected to report a 7% decline in North America direct-to-consumer sales for the third quarter, with Bank of America estimating 5% underlying growth excluding the revenue recognition change.

The bank forecasts North America direct-to-consumer sales of -7%, compared with a Visible Alpha consensus of -5%, with the difference reflecting a modeling discrepancy around the July revenue recognition change.

The change moved a large partner from direct-to-consumer to wholesale and is expected to reduce reported North America direct-to-consumer growth by 12 percentage points over the next four quarters.

The impact should be partly offset by stronger wholesale sales, with the benefit expected to be greater in the fourth quarter because of the timing of sell-in.

BofA said its underlying third-quarter direct-to-consumer growth estimate of 5% is consistent with the first half, and it expects the revenue restatement to be understood by investors.

The bank said an inflated sell-side consensus estimate for North America direct-to-consumer sales should not be problematic if Crocs provides enough disclosure to bridge restated trends on a like-for-like basis.

BofA and the broader market remain aligned with Crocs' third-quarter guidance for 1% growth in Crocs brand sales and earnings per share of $3.20 to $3.30.

The bank said momentum is broadening beyond sandals, with stabilization in classic clogs and growth across ballet flats, sport and fashion clog franchises, including Crocbrand, Echo and Crafted, as well as recovery in Mellow.

A strong pipeline of new products in the second half of 2026 and first half of 2027 should support momentum, although Bank of America expects North America direct-to-consumer growth to slow in the fourth quarter because of a tougher comparison.

BofA expects gross and operating margins to improve in the third quarter as Crocs laps tariff headwinds and cost savings increase, while higher oil prices could pressure fuel surcharges and raw material costs.

The bank maintains its buy rating, saying new products and stabilization in classic clogs could support a higher valuation multiple and further earnings-per-share upgrades.

, /PRNewswire/ -- The Board of Directors of Avient Corporation (NYSE: AVNT), an innovator of materials solutions, has declared a quarterly cash dividend of twenty-eight and a quarter cents ($0.2825) per share on the common stock outstanding, representing the sixteenth consecutive annual increase.

The $0.2825 per share will be paid on January 7, 2027, to stockholders of record on December 11, 2026. On an annualized basis, the dividend will increase from $1.10 to $1.13 per share on the common stock outstanding.

"We are pleased to increase our dividend for the sixteenth consecutive year," said Dr. Ashish Khandpur, Chairman, President and Chief Executive Officer, Avient Corporation. "Our consistent dividend growth reflects the strength of our business, our strong cash flow generation, and our commitment to returning value to shareholders through a disciplined and balanced capital allocation strategy."

About Avient

Our purpose at Avient Corporation (NYSE: AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world. Our local touch and customer engagement, combined with our global presence, allows us to serve customers with agility. We harness the collective strength of 9,000 employees worldwide to collaborate and build on each other's ideas. In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends. Our expanding portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema®, the world's strongest fiber™. By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable. Visit www.avient.com to learn more. 

SOURCE Avient Corporation

American Water to Discuss Third Quarter 2026 Results and Initiation of 2027 Standalone Earnings Guidance on October 29, 2026PR Newswire

CAMDEN, N.J., Oct. 6, 2026

, /PRNewswire/ -- American Water Works Company, Inc. (NYSE: AWK) announced today that it intends to release its 2026 third quarter financial results and 2027 earnings guidance on a standalone basis, as well as its long-term financial targets, after the market closes on Wednesday, October 28, 2026.

John Griffith, President and Chief Executive Officer; David Bowler, Executive Vice President and Chief Financial Officer; and Cheryl Norton, Executive Vice President and Chief Operating Officer, will host a conference call and webcast with investors, analysts and other interested parties on Thursday, October 29, 2026, at 9 a.m. Eastern Time. There will be a question-and-answer session as part of the call.

Interested parties may listen to an audio webcast of the conference call through a link on the Investor Relations website at ir.amwater.com. Presentation slides that will be used in conjunction with the earnings conference call will also be made available online in advance at ir.amwater.com. A replay of the audio webcast will be available for one year on American Water's investor relations website at ir.amwater.com/events. The company recognizes its websites as key channels of distribution to reach public investors and as a means of disclosing material non-public information to comply with the company's obligations under SEC Regulation FD.

About American Water
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886 and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 19 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

AWK-IR

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-water-to-discuss-third-quarter-2026-results-and-initiation-of-2027-standalone-earnings-guidance-on-october-29-2026-302900108.html

SOURCE American Water

Check the Warning Signs for

AWK

now!

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Acadia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On September 24, 2026, Acadia issued a press release “announc[ing] Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP).”  Among other data, the Company disclosed that remlifanserin at 60 mg “narrowly missed” the primary endpoint of a clinical tool designed to measure the severity of the disease. 

On this news, Acadia’s stock price fell $3.25 per share, or 12.78%, to close at $22.18 per share on September 24, 2026. 

Then, on September 25, 2026, multiple analysts downgraded Acadia, citing the disappointing trial results. 

On this news, Acadia’s stock price fell $1.50 per share, or 6.76%, to close at $20.68 per share on September 25, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

Aurora's Special Committee will commence a thorough and independent review of the revised Hostile Bid and the Board will provide a formal recommendation to shareholders once the review is complete.   Shareholders are advised to TAKE NO ACTION pending a formal recommendation. Aurora shareholders will have until at least December 4, 2026, to consider their options. Questions about the Hostile Bid or would like to stay informed? Please contact Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call or text 416-623-4172 or at [email protected]. , /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) regarding the filing of a Notice of Variation and Change to revise its hostile take-over bid (the "Hostile Bid") for all of the issued and outstanding common shares of the Company (the "Aurora Shares") to offer revised implied consideration of US$5.00 per Share, consisting of 0.4013 subordinate voting shares of Curaleaf plus US$1.00 in cash per Aurora Share.

"The filing of a revised Hostile Bid is simply the next step in the process, not a deadline to make a decision. Investors deserve the chance to review the revised Hostile Bid and decide for themselves whether it reflects the full value of the company they already own. Our Board and Special Committee are commencing their review, and until Aurora's formal recommendation is available, we urge investors to take no action," said Miguel Martin, Executive Chairman and CEO of Aurora.

"Once the review is complete, the Board will communicate its recommendation and provide the relevant information to shareholders to support them in considering their options," concluded Mr. Martin.

The Company will provide a comprehensive response to Aurora shareholders in a timely manner once the Special Committee has completed its review and the Board has made its  recommendation with respect to the revised Hostile Bid.

Take No Action

Aurora shareholders are advised to TAKE NO ACTION on the Hostile Bid as previously recommended on September 2, 2026 and to wait for further communication from the Board of Directors. Aurora shareholders will have until at least December 4, 2026, to consider their options, being the revised expiry date of Curaleaf's Hostile Bid.

The Special Committee will consider the Hostile Bid with its advisors before making a recommendation to the Board. Aurora shareholders will be notified of the Board's formal recommendation through a news release and Directors' Circular.

Shareholder Assistance

Aurora shareholders with questions about the Hostile Bid or who would like to stay informed may contact Kingsdale Advisors, the Company's strategic advisor and information agent:

Toll-Free (within North America): 1-800-749-9052 Call or Text: 416-623-4172 Email: [email protected] Visit protectaurora.com About Aurora Cannabis

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™. 

Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Aurora has filed a Solicitation/Recommendation Statement on Schedule 14D-9F with the U.S. Securities and Exchange Commission (the "SEC"), which includes a Director's Circular, dated September 1, 2026. Investors are urged to read this document and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, when they become available, before making any investment decision with respect to the Hostile Bid. The Hostile Bid is made for the securities of a Canadian issuer and while the Hostile Bid is subject to disclosure requirements of Canada, investors should be aware that these requirements are different from those of the United States. The enforcement by investors of civil liabilities under the U.S. federal securities laws may be affected adversely by the fact that the issuer is located in Canada, and that some or all of its officers and directors are residents of Canada.

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements and information about Curaleaf's revised Hostile Bid, including the revised consideration, the Special Committee's planned review of the revised Hostile Bid and any recommendation with respect to the same.

These forward-looking statements are only predictions. Forward-looking information or statements contained in this news release have been developed based on the Company and its management's good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and affect the Company's business and operations in the future. Forward-looking information and statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management at the date the statements are made including, among other things, assumptions about: development costs remaining consistent with budgets; the ability to manage anticipated and unanticipated costs; access to favorable equity and debt capital markets; the ability to raise sufficient capital to advance the business of the Company; favorable operating and economic conditions; political and regulatory stability; obtaining and maintaining all required licenses and permits; receipt of governmental approvals and permits; sustained labour stability; stability in financial and capital goods markets; favorable production levels and costs from the Company's operations; the pricing of various cannabis products; the level of demand for cannabis products; the availability of third-party service providers and other inputs for the Company's operations; and the Company's ability to conduct operations in a safe, efficient, and effective manner. The Company does not give any assurance that the assumptions on which forward-looking information or statements are based will prove to be correct, or that the Company's business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company's control. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete construction projects and facilities improvements, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion to revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crisis, and other risks as set out under the heading "Risk Factors" in the Company's annual information form dated June 10, 2026 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE Aurora Cannabis Inc.